Article
Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D.
Prenatal diagnosis - 1 Dec 2010
Pirelli Kevin J, Pietz Bradley C, Johnson Susan T, Pinder Holly L, Bellissimo Daniel B
Abstract excerpt
OBJECTIVE: Development of an accurate molecular method for paternal RHD zygosity to predict risk to a fetus for hemolytic disease of the fetus and newborn (HDFN) related to anti-D. METHODS: Quantitative fluorescence polymerase chain reaction (QF-PCR) was used to detect RHD exons 5 and 7, using RHCE exon 7 as an internal control. The genotype and zygosity were determined from the peak area ratios of RHD exon 5 or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
